OAB and Incontinence

Preoperative bladder symptom score best predictor of transvaginal mesh surgery success

September 16, 2020

“Although IPSS may not be familiar to gynecologists and urogynecologists, this minimally invasive self-reported questionnaire is useful in counseling preoperative pelvic organ prolapse patients with OAB symptoms," researchers write.

Three-week test phase improves odds of success for sacral neuromodulation

September 16, 2020

“The present study clearly shows that test duration and reprogramming during the test phase increases the number of patients that benefit in the long term from sacral neuromodulation,” researchers wrote.

Telemedicine is viable option for most early midurethral sling postoperative visits

September 15, 2020

Outcomes for patients using telemedicine were equal, and patients were as satisfied as those who had office-based postoperative visits.

Smoking associated with increased incidence of OAB

September 08, 2020

Smoking had a particularly strong impact on OAB risk in younger individuals.

Overactive bladder: Another agent attempts a step forward

September 03, 2020

Gopal H. Badlani, MD, discusses the recently presented long-term safety profile of the β-3 adrenoceptor agonist vibegron.

Nocturia: How to define it, and how to treat it

August 25, 2020

Jeffrey P. Weiss, MD, PhD, discusses how he defines nocturia, how to separate the symptom from overactive bladder, and how he conducts patient work-ups for nocturia

FDA approval sought for peripheral neurostimulator for overactive bladder

August 24, 2020

Data from a pivotal trial showed the eCoin Peripheral Neurostimulator led to a clinically significant improvement in urgency urinary incontinence.

Overactive bladder treatment maintains favorable long-term safety profile

August 21, 2020

Beta 3-adrenergic receptor agonist’s benefits observed at 52 weeks, investigators report.

Pivotal study launches exploring novel device for women with OAB

August 11, 2020

The OASIS study is examining the RENOVA iStim implantable tibial neuromodulation system for the treatment of women with overactive bladder.

FDA approves new devices for bladder and bowel control conditions

August 06, 2020

InterStim Micro treats patients with overactive bladder, fecal incontinence, and non-obstructive urinary retention by delivering sacral neuromodulation therapy.